CalciMedica, Inc. Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions
CalciMedica, Inc. (CALC) reported Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions of $345.00 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-03.
Financial Statements › Notes › Income Taxes › Income Tax Uncertainties
us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions · last filed 2026-03-03
- CalciMedica, Inc. unrecognized tax benefits, increase resulting from current period tax positions for fiscal 2025 was $345.00K, a 3.29% increase from fiscal 2024.
- CalciMedica, Inc. unrecognized tax benefits, increase resulting from current period tax positions for fiscal 2024 was $334.00K, a 88.26% decline from fiscal 2023.
- CalciMedica, Inc. unrecognized tax benefits, increase resulting from current period tax positions for fiscal 2023 was $2.85M, a 192.50% increase from fiscal 2022.
- CalciMedica, Inc. unrecognized tax benefits, increase resulting from current period tax positions for fiscal 2022 was $973.00K, a 278.60% increase from fiscal 2021.
| Period end | Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions 12 month | Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions 12 month as first filed |
|---|---|---|
| 2025-12-31 | $345.00K 10-K · filed 2026-03-03 | |
| 2024-12-31 | $334.00K 10-K · filed 2026-03-03 | |
| 2023-12-31 | $2.85M 10-K · filed 2025-03-27 | |
| 2022-12-31 | $973.00K 10-K · filed 2024-03-28 | $155.00K 10-K · filed 2023-03-09 |
| 2021-12-31 | $257.00K 10-K · filed 2023-03-09 | |
| 2020-12-31 | $406.00K 10-K · filed 2022-03-11 | |
| 2019-12-31 | $533.00K 10-K · filed 2021-03-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| Skye Bioscience, Inc. (SKYE) | United States | $0.061B | -0.48 |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| Rein Therapeutics, Inc. (RNTX) | United States | $0.063B | -1.76 |
| HYPERION DEFI, INC. (HYPD) | United States | $0.065B | |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |